Subsys is a prescription medication that contains the active ingredient fentanyl, a powerful opioid pain reliever. It is used to manage breakthrough cancer pain in patients who are already receiving around-the-clock opioid therapy for their underlying persistent cancer pain. Breakthrough pain is a sudden and intense flare-up of pain that occurs despite the use of regular pain medications.

Subsys is available as a sublingual spray, which means it is administered under the tongue for rapid absorption into the bloodstream. This allows for quick relief of breakthrough pain, usually within 5 to 15 minutes after administration. It is important to follow the dosing instructions provided by your healthcare provider to ensure safe and effective use of Subsys.

As with all opioid medications, Subsys carries a risk of misuse, abuse, addiction, and overdose. It should only be used as prescribed by a healthcare professional and should be stored securely to prevent unauthorized use. Common side effects of Subsys may include nausea, constipation, dizziness, and drowsiness.

If you have a history of substance abuse, respiratory problems, or certain medical conditions, be sure to discuss these with your healthcare provider before starting Subsys. They can help determine if this medication is appropriate for you and monitor your response to treatment.

Overall, Subsys can be a valuable tool in managing breakthrough cancer pain when used appropriately under the guidance of a healthcare provider. If you have any questions or concerns about Subsys or your pain management plan, don’t hesitate to reach out to your healthcare team for support and guidance.